Lucid Diagnostics Inc. LUCD
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.44M | 5.45M | 5.13M | 4.71M | 4.40M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.44M | 5.45M | 5.13M | 4.71M | 4.40M |
| Cost of Revenue | 6.33M | 6.63M | 6.75M | 6.67M | 6.96M |
| Gross Profit | -897.00K | -1.18M | -1.61M | -1.97M | -2.56M |
| SG&A Expenses | 44.58M | 43.69M | 41.78M | 41.58M | 39.62M |
| Depreciation & Amortization | 420.00K | 420.00K | 420.00K | 420.00K | 421.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 56.64M | 56.13M | 54.40M | 54.35M | 52.40M |
| Operating Income | -51.20M | -50.69M | -49.27M | -49.64M | -48.01M |
| Income Before Tax | -48.54M | -52.26M | -45.01M | -58.01M | -53.29M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -48.54 | -52.26 | -45.01 | -58.01 | -53.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -48.54M | -52.26M | -45.01M | -58.01M | -53.29M |
| EBIT | -51.20M | -50.69M | -49.27M | -49.64M | -48.01M |
| EBITDA | -50.32M | -49.81M | -48.40M | -48.77M | -47.12M |
| EPS Basic | -0.41 | -0.47 | -0.47 | -0.82 | -0.90 |
| Normalized Basic EPS | -0.20 | -0.23 | -0.26 | -0.32 | -0.38 |
| EPS Diluted | -0.41 | -0.47 | -0.47 | -0.82 | -0.90 |
| Normalized Diluted EPS | -0.20 | -0.23 | -0.26 | -0.32 | -0.38 |
| Average Basic Shares Outstanding | 645.56M | 562.79M | 478.66M | 407.35M | 334.34M |
| Average Diluted Shares Outstanding | 645.56M | 562.79M | 478.66M | 407.35M | 334.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |